Viveve Medical Inc VIVE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:30 AM EST
3.69UNCH (UNCH)
Volume
320
Close
3.69quote price arrow down-0.19 (-4.90%)
Volume
824,399
52 week range
3.03 - 14.40

...

Loading . . .

KEY STATS

  • Open4.05
  • Day High4.05
  • Day Low3.60
  • Prev Close3.69
  • 52 Week High14.40
  • 52 Week High Date08/25/20
  • 52 Week Low3.03
  • 52 Week Low Date01/14/21
  • Market Cap28.93M
  • Shares Out7.84M
  • 10 Day Average Volume1.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • 1 Year % Change-71.17

RATIOS/PROFITABILITY

  • EPS (TTM)-60.35
  • P/E (TTM)-0.06
  • Fwd P/E (NTM)-0.62
  • EBITDA (MRQ)-19.902M
  • ROE (MRQ)-1,008.81%
  • Revenue (MRQ)4.98M
  • Gross Margin (MRQ)-1.40%
  • Net Margin (MRQ)-631.31%
  • Debt To Equity (MRQ)51.58%

EVENTS

  • Earnings Date03/17/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Viveve Medical Inc News

There is no recent news for this security.

Latest VIVE News From Our Partners

QUOTE FINDER

Profile

MORE
Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other...
Steven Basta
Chairman
Scott Durbin
Chief Executive Officer
Jim Robbins CPA
Chief Financial Officer
Sean Shapiro
Vice President
Address
345 Inverness Dr S Bldg B Ste 250
Englewood, CO
80112-5889
United States